BRÈVE publiée le 10/10/2024 à 18:39, il y a 2 années Fuller, Smith & Turner PLC: Share Buyback Update London Stock Exchange Share Buyback Market Abuse Regulation Fuller, Smith & Turner PLC Treasury Shares
BRÈVE publiée le 10/10/2024 à 18:39, il y a 2 années Fuller, Smith & Turner PLC : mise à jour sur le rachat d'actions Actions Propres Rachat D'actions Bourse De Londres Réglementation Sur Les Abus De Marché Fuller, Smith & Turner SA
COMMUNIQUÉ DE PRESSE publié le 10/10/2024 à 18:34, il y a 2 années Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program, holding shares in Treasury. Details of transaction provided London Stock Exchange Share Buyback Program Numis Securities Limited Fuller Smith Turner PLC Own Shares
BRÈVE publiée le 09/10/2024 à 18:32, il y a 2 années Fuller, Smith & Turner PLC Acquires Own Shares in Buyback Programme London Stock Exchange Share Buyback Treasury Shares Securities Acquisition Fuller’s PLC
BRÈVE publiée le 09/10/2024 à 18:32, il y a 2 années Fuller, Smith & Turner PLC acquiert ses propres actions dans le cadre d'un programme de rachat Actions Propres Rachat D'actions Bourse De Londres Acquisition De Titres PLC De Fuller
COMMUNIQUÉ DE PRESSE publié le 09/10/2024 à 18:27, il y a 2 années Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program. Company bought 1,000 'A' ordinary shares on LSE London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited Own Shares Transaction
BRÈVE publiée le 08/10/2024 à 18:33, il y a 2 années Fuller, Smith & Turner PLC: Share Buyback Update London Stock Exchange Share Buyback Treasury Shares Numis Securities Fuller, Smith & Turner
BRÈVE publiée le 08/10/2024 à 18:33, il y a 2 années Fuller, Smith & Turner PLC : mise à jour sur le rachat d'actions Actions Propres Rachat D'actions Numis Securities Bourse De Londres Fuller, Smith Et Turner
COMMUNIQUÉ DE PRESSE publié le 08/10/2024 à 18:28, il y a 2 années Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 2,890 'A' ordinary shares at an average price of 736.00 GBp as part of their share buyback program London Stock Exchange Ordinary Shares Share Buyback Fuller, Smith & Turner PLC Numis Securities Limited
BRÈVE publiée le 07/10/2024 à 18:45, il y a 2 années Fuller’s Acquires Own Shares Through Buyback Programme Voting Rights London Stock Exchange Share Buyback Treasury Shares Fuller’s
Publié le 04/11/2026 à 18:00, il y a 8 heures 59 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 8 heures 59 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 9 heures 15 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 3 heures 49 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 3 heures 59 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 4 heures 44 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 4 heures 54 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 00:02, il y a 2 heures 56 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 7 heures 18 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 7 heures 34 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 8 heures 16 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Publié le 04/11/2026 à 18:05, il y a 8 heures 54 minutes Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
